Pharmafile Logo

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

April 22, 2024 |  

Authored by: Ellie Forde and Mark Braund, Directors

- PMLiVE

The integration of Artificial Intelligence (AI) in the world of healthcare has opened new frontiers in medical research, patient care, and now in market research. Attending the 2024 UK One Day EphMRA meeting in London on this evolving topic provided thoughtful insights into how AI technologies are not just augmenting, but fundamentally starting to change in how we run healthcare market research. This summary delves into the key themes, innovations, and presentations from a range of experts in the field, offering a glimpse into the future of healthcare market research.

Read the full write up here.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry